COVID-19 Media

Print Media

CFI is continuing the fight against COVID-19. Below is a collection of articles that showcase CFI's efforts.

 

UMN research could help inform future COVID-19 vaccines

The Minnesota Daily's Madeline Deninger writes about how Dr. Marc Jenkins and other members of CFI have been working to understand how the body develops antibodies once it has been infected with COVID-19. Click here

Dr. Marc Jenkins is quoted in an article by Elizabeth Weise published on May 8, 2020 in USA Today about whether it is possible to catch the coronavirus twice.

Drs. Amy Karger and Marc Jenkins provided factual information to The Wall Street Journal about antibody tests—blood tests designed to detect who was previously infected with the new coronavirus and have developed antibodies to it. Click here

CFI director Dr. Marc Jenkins explains how the University of Minnesota and Mayo Clinic are close to unveiling antibody tests that can determine if people have already been infected by the coronavirus that causes COVID-19 and are no longer threats to get or spread the infection. To read the entire Star Tribune article from March 30, 2020 click here.

The Star Tribune's Christopher Snowbeck and CFI's Director Marc Jenkins talk about "a whole new approach to vaccines" using viral RNA instead of the way current vaccines are produced using a weakened or killed form of a virus to stimulate an immune system response that produces antibodies.  To read the entire Star Tribune article click here.

Radio and TV

Local News and Seminars

Dr. Marc Jenkins joined Fox9 Morning Buzz on 7-29-20 to answer questions about COVID-19 vaccines and how UMN is following less traveled roads to find a long term solution.

Marc talks with Tolar

KARE-11 interview with Jennifer Austin on July 14, 2020.

Fox9 the Morning Buzz interview with Alex Kendall and Ryan Langlois

Morning Buzz 5-14-20

Department of Orthopedic Surgery Grand Rounds: 5-8-2020GRAND ROUNDS 5-8-20

KARE-11 interview with Chris Hrapsky on May 7, 2020

KARE 11 5-7-20

KARE-11 interview with Kent Erdahl on April 15, 2020 

Kare 11 4-15-20 

KARE-11 (4/1/2020)

KARE-11 4-1-20

  

UMN articles

CFI and UMN Collaborators articles

A new vaccine development approach, now being studied at the University of Minnesota Medical School, hopes to protect against current and future strains of SARS-CoV-2 (COVID-19). Drs. Geoffrey Hart and Marco Pravetoni have partnered together to prove that a universal vaccine or antibodies are possible in the fight against future variants of SARS-CoV.

Responses by Drs. Matt Pullen, MD- Infectious Diseases Fellow and David Boulware, MD, MPH, Professor of Medicine- Infectious Diseases on current data, what are the recommendations for use of hydroxychloroquine in SARS-CoV-2 infection?

Dr. Tyler Bold explains how sera from patients who have recovered from SARS-CoV-2 infection (convalescent sera) could be used immediately to provide protective immunity.

What have we and what can we learn from the sequences of the SARS-Cov-2 genome as the viruse mutates and spreads around the world? 

Dr. Karger discusses the need to create and validate the UMN laboratory-developed tests for COVID-19. Marc Jenkins, PhD, and Fang Li, PhD, had laid the foundation for a new antibody (or serology) test but needed a leader and a lab to bring it up for clinical use. Dr. Karger stepped in.

Interview with Dr. Marc Jenkins on the Antibody Testing Capabilities Developed at the University of Minnesota for SARS-CoV2

What vaccines are under development, and how would they work to prevent COVID-19 infection?

What are the most promising drugs currently being tested against the COVID-19 coronavirus, and how do they work?

 “Structural basis of receptor recognition by SARS-CoV-2" Nature, March 20, 2020.

This paper discuses the 3-dimensional structure determined by Dr. Fang Li in collaboration with Dr. Hideki Aihara.